Evidence map›Paper›PMID 34209394›Full record

ArticleToxins2021

Douglas Souza Oliveira, Jean Gabriel de Souza, Miryam Paola Alvarez-Flores, Priscila S Cunegundes, Carlos DeOcesano-Pereira, Aline Maia Lobba, Renata N Gomes, Ana Marisa Chudzinski-Tavassi

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Venom-Derived Proteins fromInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Losac and Lopap Recombinant Proteins fromFrontiers in molecular biosciences · 2022
    Article
  4. Toxins · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Douglas Souza OliveiraCentre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil.
Jean Gabriel de SouzaCentre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil.
Miryam Paola Alvarez-FloresCentre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil.ORCID 0000-0002-7986-923X
Priscila S CunegundesCentre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil.
Carlos DeOcesano-PereiraCentre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil.ORCID 0000-0002-8933-4474
Aline Maia LobbaCentre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil.
Renata N GomesCentre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil.
Ana Marisa Chudzinski-TavassiCentre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil.
Instituto Butantan · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 303197/2017-0Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 1757645Fundação de Amparo à Pesquisa do Estado de São Paulo 2013/07467-1Fundação de Amparo à Pesquisa do Estado de São Paulo 2015/50040-4
6 · The paper itself

Abstract

Envenomation caused by contact with

Indexed as

LarvaAnimalsAntigens, CDArthropod VenomsB7-1 AntigenCD83 AntigenCell SurvivalCytokinesGene Expression RegulationHumansImmunoglobulinsLepidopteraMacrophagesMembrane GlycoproteinsNF-kappa BTHP-1 CellsAntigens, CDArthropod VenomsB7-1 AntigenCD83 AntigenCytokinesImmunoglobulinsMembrane GlycoproteinsNF-kappa BInflammationLonomia obliquamacrophage activation

Identifiers

PMID34209394
PMCPMC8309978
OpenAlexW3176477770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.